Novo shares lost nearly a fifth of their value after an experimental combination treatment called cagrisema fell short of the ...

The clearance of Tryngolza gives Ionis its first wholly-owned, marketed medicine. Elsewhere, Robert Temple became the latest ...

Dec. 21, 2024 – Dec. 31, 2024 • New York, NY, USA, New York ...